NCMB 312: Concepts of Fluids, Electrolytes, Acid-Base Imbalances, Burns, Renal Disorders, and Communicable Diseases

Comprehensive practice flashcards for BSN 3rd Year Midterm Examination reviewing fluid and electrolyte physiology, imbalances, acid-base regulation, burn injuries and fluid resuscitation, renal disorders, communicable disease transmission, immunology, EPI schedules, and key infectious diseases.

Intracellular Fluid (ICF)

The fluid contained within all body cells, accounting for approximately $40\%$ of total body weight (or $63\%$ of total body water), in which potassium ($K^+$), phosphate ($PO_4^{3-}$, $HPO_4^{2-}$), and magnesium ($Mg^{2+}$) serve as the predominant electrolytes.

Extracellular Fluid (ECF)

The fluid located outside the cells, comprising approximately $20\%$ of body weight (or $37\%$ of total body water), divided into interstitial fluid ($15\%$), intravascular fluid or plasma ($5\%$), and transcellular fluids (including CSF, pleural, peritoneal, and synovial fluids), with sodium ($Na^+$), chloride ($Cl^-$), and bicarbonate ($HCO_3^-$) as primary ions.

Kayser-Jones Daily Fluid Intake Formula

A standard clinical formula calculating daily oral fluid intake requirements as $100\,\text{mL/kg}$ for the first $10\,\text{kg}$ of body weight, plus $50\,\text{mL/kg}$ for the next $10\,\text{kg}$, plus $15\,\text{mL/kg}$ for each remaining kilogram of body weight.

Sensible Fluid Loss

Measurable and noticeable fluid elimination from the body, primarily consisting of urination ($1{,}400\text{--}1{,}500\,\text{mL/day}$, or $30\text{--}50\,\text{mL/hr}$, or $0.5\text{--}1\,\text{mL/kg/hr}$) and fecal output ($100\text{--}200\,\text{mL/day}$).

Insensible Fluid Loss

Unnoticeable, continuous, and unmeasurable fluid loss occurring through vaporization from the lungs ($350\text{--}400\,\text{mL/day}$) and diffusion through the skin ($350\text{--}400\,\text{mL/day}$), which increases by $100\text{--}150\,\text{mL/day}$ for each degree Celsius elevation above $37^\circ\text{C}$.

Osmoreceptors

Specialized sensory neurons located in the hypothalamus that detect changes in serum osmolality; increased osmolality stimulates antidiuretic hormone (ADH) secretion and triggers thirst, whereas decreased osmolality suppresses ADH release.

Renin-Angiotensin-Aldosterone System (RAAS)

A neuroendocrine compensatory mechanism activated by decreased extracellular fluid volume or reduced renal perfusion pressure, leading to the sequential conversion of angiotensinogen to angiotensin I and angiotensin II, resulting in systemic vasoconstriction and aldosterone release to promote renal sodium and water retention.

Natriuretic Peptides (ANP and BNP)

Cardiac hormones secreted in response to overstretching of the atrial and ventricular myocardial walls that act as potent natriuretic and diuretic agents by inhibiting renin, aldosterone, and ADH release, thereby decreasing blood volume and suppressing thirst.

Tonicity

The relative concentration of solute particles in an extracellular fluid solution compared to normal plasma, which has a physiological osmolarity of $275\text{--}300\,\text{mOsm/L}$ (comparable to isotonic $0.9\%\,\text{NaCl}$).

Osmosis

The net passive movement of water or solvent molecules across a selectively semipermeable membrane from an area of lower solute concentration (higher solvent concentration) to an area of higher solute concentration.

Colloidal Osmotic Pressure (Oncotic Pressure)

The pulling force exerted within the intravascular space by large non-diffusible plasma proteins (primarily albumin, along with globulin and fibrinogen) that draws water from the interstitial fluid space into the blood capillaries.

Hydrostatic Pressure

The physical pushing force exerted by fluid against the capillary membrane within a closed circulatory compartment, driving water and dissolved solutes outward into the interstitial space when it exceeds opposing osmotic pressure.

Diffusion

The passive transport of solute particles, ions, or molecules down a concentration gradient from an area of higher concentration to an area of lower concentration through a permeable or semipermeable membrane.

Facilitated Diffusion

A form of passive carrier-mediated transport wherein substances move across a semipermeable cell membrane down their concentration gradient with the assistance of a specific transport protein without the expenditure of cellular energy, such as glucose entry mediated by insulin.

Active Transport

The movement of solute particles across a cell membrane against a concentration gradient (from an area of lower concentration to an area of higher concentration) requiring metabolic energy in the form of adenosine triphosphate ($\text{ATP}$), exemplified by the sodium-potassium ($Na^+\text{--}K^+$) pump.

Serum Osmolality Formula

A mathematical formula used to estimate total solute concentration in serum, calculated as $\text{Osm}_{\text{serum}} = 2(Na) + \text{BUN} + \text{glucose}$, with a normal physiological reference range of $285\text{--}295\,\text{mOsm/kg}$.

Sodium ($Na^+$)

The predominant extracellular cation (normal reference range: $135\text{--}145\,\text{mEq/L}$ or $\text{mmol/L}$), serving as the principal determinant of extracellular fluid volume and plasma osmolality, and essential for generating and transmitting action potentials across neuromuscular membranes.

Potassium ($K^+$)

The major intracellular cation (normal extracellular range: $3.5\text{--}5.0\,\text{mEq/L}$; intracellular concentration: approximately $140\,\text{mEq/L}$), vital for regulating intracellular osmolality, protein synthesis, cellular glycogen deposition, and electrical membrane excitability in the myocardium and skeletal muscles.

Calcium ($Ca^{2+}$)

An essential cation (normal total serum range: $9.0\text{--}10.5\,\text{mg/dL}$ or $2.25\text{--}2.75\,\text{mmol/L}$; ionized active form: $4.7\text{--}5.3\,\text{mg/dL}$) that stabilizes excitable cell membranes, strengthens bone and tooth matrix, mediates blood coagulation, and enables muscle fiber contraction.

Phosphorus ($P$)

The primary intracellular anion (normal serum range: $3.0\text{--}4.5\,\text{mg/dL}$ or $0.97\text{--}1.45\,\text{mmol/L}$), $85\%$ of which is stored in bone alongside calcium, functioning in high-energy ATP bond generation, acid-base buffering, B-vitamin activation, and cell division.

Magnesium ($Mg^{2+}$)

The second most abundant intracellular cation (normal serum range: $1.3\text{--}2.1\,\text{mEq/L}$ or $0.66\text{--}1.07\,\text{mmol/L}$), predominantly stored in bone ($50\text{--}60\%$) and muscle, acting as a crucial enzyme cofactor for carbohydrate metabolism, protein synthesis, nucleic acid assembly, and neuromuscular transmission.

Chloride ($Cl^-$)

The primary extracellular anion (normal serum range: $98\text{--}106\,\text{mEq/L}$ or $\text{mmol/L}$), which pairs with sodium to regulate extracellular osmotic pressure, participates in the chloride-bicarbonate shift in red blood cells, and enables gastric hydrochloric acid ($\text{HCl}$) formation.

Hypovolemia (Fluid Volume Deficit)

An isotonic decrease in extracellular fluid volume caused by fluid loss exceeding oral intake, where water and electrolytes are lost in equal proportions, manifesting with thirst, rapid thready pulse, postural hypotension, oliguria, hemoconcentration, and poor skin turgor.

Third Spacing

The pathophysiologic shift and accumulation of intravascular fluid into non-functional body spaces or tissue compartments (e.g., peritoneal ascites, burn edema, pleural space) where it remains trapped and physiologically useless, leading to circulating hypovolemia and shock.

Hypervolemia (Overhydration)

An excess of fluid volume within the intravascular and interstitial compartments, resulting from heart failure, renal failure, or rapid IV infusion, characterized by rapid weight gain, elevated central venous pressure ($> 10\,\text{cm }H_2O$), pulmonary crackles, jugular venous distention, and dependent pitting edema.

Hyponatremia

A serum sodium concentration below $135\,\text{mEq/L}$, resulting from excessive water retention, diuretic therapy, or gastrointestinal losses, clinically presenting with anorexia, nausea, muscular weakness, confusion, personality changes, and in severe cases, cerebral edema, seizures, and coma.

Hypernatremia

A serum sodium concentration exceeding $145\,\text{mEq/L}$, typically caused by profuse watery diarrhea, reduced water intake, or osmotic diuresis, manifesting with intense thirst, rough dry sticky mucous membranes, fever, oliguria, lethargy, and hyperreflexia.

Hypokalemia

A serum potassium level below $3.5\,\text{mEq/L}$, precipitated by potassium-wasting diuretics, prolonged vomiting, or diarrhea, characterized clinically by muscle weakness, fatigue, paresthesias, abdominal distention, and ECG changes including ST-segment depression, flattened T waves, and prominent U waves.

Hyperkalemia

A serum potassium level exceeding $5.0\,\text{mEq/L}$, caused by renal failure, severe crush injury, burns, or acidosis, manifesting with nausea, diarrhea, flaccid muscle weakness, paresthesias, and life-threatening ECG alterations including tall peaked T waves, prolonged PR intervals, absent P waves, and widened QRS complexes.

Hypocalcemia

A total serum calcium level below $9.0\,\text{mg/dL}$ (or $< 2.25\,\text{mmol/L}$), caused by hypoparathyroidism, vitamin D deficiency, or pancreatitis, manifesting with neuromuscular irritability, tetany, carpopedal spasms, laryngeal stridor, and positive Chvostek's and Trousseau's signs.

Chvostek's Sign and Trousseau's Sign

Classical physical assessment signs of latent tetany in hypocalcemia or hypomagnesemia: Chvostek's sign is unilateral facial muscle twitching elicited by tapping over the facial nerve anterior to the ear; Trousseau's sign is carpopedal spasm induced by occluding arterial blood flow with an inflated blood pressure cuff for 3 minutes.

Hypercalcemia

A serum calcium level exceeding $10.5\,\text{mg/dL}$ (or $> 2.75\,\text{mmol/L}$), commonly caused by hyperparathyroidism or malignancies, presenting with deep bone pain, pathologic fractures, anorexia, constipation, polyuria, nephrolithiasis, and shortened QT intervals on ECG.

Hypomagnesemia

A serum magnesium concentration below $1.3\,\text{mEq/L}$ (or $< 1.5\,\text{mEq/L}$), caused by chronic alcoholism, malnutrition, or diuretic overuse, manifesting with neuromuscular hyperirritability, paresthesias, leg cramps, cardiac dysrhythmias, and refractory hypokalemia.

Hypermagnesemia

A serum magnesium level exceeding $2.1\,\text{mEq/L}$ (or $> 2.5\,\text{mEq/L}$), typically occurring in renal insufficiency accompanied by the ingestion of magnesium-containing antacids or laxatives, characterized by peripheral flushing, warmth, hypotension, bradycardia, lethargy, loss of deep tendon reflexes, and respiratory depression.

Hypophosphatemia

A serum inorganic phosphorus level below $2.5\,\text{mg/dL}$ (or $< 3.0\,\text{mg/dL}$), resulting from hyperparathyroidism, refeeding syndrome, DKA recovery, or aluminum hydroxide antacids, causing generalized muscle weakness, acute respiratory muscle failure, tremors, bone pain, and encephalopathy.

Hyperphosphatemia

A serum phosphorus concentration exceeding $4.5\,\text{mg/dL}$, primarily caused by acute or chronic renal failure and hypoparathyroidism, leading to reciprocal hypocalcemia, secondary hyperparathyroidism, and precipitation of insoluble calcium-phosphate crystals in soft tissues, blood vessels, and skin.

Bicarbonate Buffer System

The principal chemical buffering system of the extracellular fluid, consisting of carbonic acid ($H_2CO_3$) as a weak acid and sodium bicarbonate ($NaHCO_3$) as a weak base, maintained in a normal physiological ratio of $20:1$ ($HCO_3^-$ to $H_2CO_3$) to preserve normal plasma pH.

Phosphate Buffer System

An active chemical buffer system operating primarily within the intracellular fluid and renal tubular lumens (urine), composed of dihydrogen phosphate ($NaH_2PO_4^-$) acting as a weak acid and monohydrogen phosphate ($Na_2HPO_4^{2-}$) acting as a weak base.

Protein Buffer System

The body's most plentiful and powerful chemical buffer system, utilizing plasma proteins, intracellular proteins, and erythrocyte hemoglobin to reversibly bind or release hydrogen ions ($H^+$) depending on ambient physiological pH.

Amphoteric Molecules

Protein or amino acid molecules capable of functioning chemically as either a weak acid (via their free carboxyl groups, $-\text{COOH}$) or a weak base (via their free basic amino groups, $-\text{NH}_2$) to resist shifts in systemic hydrogen ion concentration.

Arterial Blood Gas (ABG) Reference Ranges

Standard clinical laboratory values for arterial blood: pH = $7.35\text{--}7.45$, $PaCO_2$ = $35\text{--}45\,\text{mmHg}$, $HCO_3^-$ = $22\text{--}26\,\text{mEq/L}$, $PaO_2$ = $80\text{--}100\,\text{mmHg}$, Base Excess = $-2\text{ to }+2\,\text{mEq/L}$, and $O_2$ saturation = $95\text{--}98\%$.

Metabolic Acidosis

An acid-base disturbance characterized by an arterial pH below $7.35$ and an arterial bicarbonate ($HCO_3^-$) level below $22\,\text{mEq/L}$, resulting from accumulation of non-carbonic organic acids (e.g., ketoacids, lactic acid) or severe intestinal bicarbonate loss.

Kussmaul's Respiration

A deep, rapid, and labored pattern of breathing that represents the respiratory system's rapid compensatory attempt to excrete excess carbon dioxide ($CO_2$) in the presence of severe metabolic acidosis.

Metabolic Alkalosis

An acid-base imbalance marked by an arterial pH above $7.45$ and a serum bicarbonate ($HCO_3^-$) level above $26\,\text{mEq/L}$, caused by massive loss of hydrogen ions (via vomiting or gastric suction), hypokalemia, or excessive ingestion of alkaline salts, compensated for by hypoventilation.

Respiratory Acidosis

An acid-base disorder defined by an arterial pH below $7.35$ and an elevated $PaCO_2$ above $45\,\text{mmHg}$, caused by alveolar hypoventilation or impaired gas exchange (e.g., COPD, atelectasis, pneumonia, head trauma, or drug overdose), with renal compensation involving hydrogen ion excretion and bicarbonate retention.

Respiratory Alkalosis

An acid-base disturbance characterized by an arterial pH above $7.45$ and a low $PaCO_2$ below $35\,\text{mmHg}$, caused by alveolar hyperventilation (e.g., severe anxiety, high fever, or mechanical overventilation), producing cerebral vasoconstriction, lightheadedness, and circumoral paresthesias.

Level of Compensation (Acid-Base)

The physiological stage of compensatory response to an acid-base disorder: uncompensated (pH abnormal, only one buffer component altered); partially compensated (both $PaCO_2$ and $HCO_3^-$ abnormal, but pH remains outside normal limits); and fully compensated (pH has returned to normal limits while both $PaCO_2$ and $HCO_3^-$ remain abnormal).

Superficial-Thickness Burn

A burn injury limited solely to the epidermis (such as a mild sunburn or flash burn), presenting with pink-to-red erythema, mild edema, local pain, absence of blisters, and complete desquamation and healing in $3\text{--}5\,\text{days}$ without scar formation.

Superficial Partial-Thickness Burn

A burn injury extending through the epidermis into the upper third of the dermis, characterized by bright pink-to-red, moist, blanchable tissue, prominent blister formation from plasma extravasation, severe pain due to intact exposed nerve endings, and healing in $10\text{--}21\,\text{days}$.

Deep Partial-Thickness Burn

A burn involving the epidermis and extending deep into the reticular dermis, appearing mottled red-to-white, dry, with rare blisters, moderate edema, and reduced pain perception due to extensive nerve destruction, typically healing in $3\text{--}6\,\text{weeks}$ with scar formation.

Full-Thickness Burn

A severe burn destroying the entire epidermis and dermis with no remaining epithelial cells, presenting as dry, leathery, waxy white, brown, or charred black inelastic eschar that is completely insensate, avascular, and requires surgical debridement and grafting to heal.

Deep Full-Thickness Burn

An extensive thermal or electrical burn extending completely through all cutaneous layers into underlying fascia, skeletal muscle, and bone, characterized by charred, blackened, depressed tissue with absent sensation, necessitating aggressive surgical debridement or amputation.

Rule of Nines

A rapid anatomical estimation tool used in adult burn assessment that assigns percentages to body regions: head and neck = $9\%$, each upper extremity = $9\%$ (total $18\%$), anterior trunk = $18\%$, posterior trunk = $18\%$, each lower extremity = $18\%$ (total $36\%$), and genitalia = $1\%$, totaling $100\%$ of total body surface area (TBSA).

Berkow Method (Lund and Browder Chart)

A precise burn assessment chart that estimates total body surface area (TBSA) burned by adjusting anatomical percentages according to the patient's age and developmental growth, accounting for the disproportionately larger head size and smaller extremities of infants and children.

Palm Method

A quick bedside assessment technique particularly useful for estimating scattered, patchy burn injuries, where the surface area of the patient's own palm (excluding fingers) represents approximately $1\%$ of their total body surface area (TBSA).

Inhalation Injury

Thermal, chemical, or systemic respiratory tract damage resulting from exposure to hot smoke and toxic combustion products, suspected in patients with enclosed-space exposure, facial burns, singed nasal hairs, carbonaceous sputum, hoarseness, and inspiratory stridor.

Capillary Leak Syndrome

The early post-burn pathophysiologic response wherein microvascular endothelial permeability increases dramatically, allowing massive loss of plasma water, electrolytes, and large protein molecules into the interstitial space, leading to extensive tissue edema and burn shock.

Parkland (Baxter) Formula

A widely used crystalloid fluid resuscitation protocol for the first $24\,\text{hours}$ following major burn injury: $4\,\text{mL} \times \text{body weight (kg)} \times \%\text{TBSA burned}$ of Lactated Ringer's solution, with $50\%$ administered in the first $8\,\text{hours}$ from the time of burn and the remaining $50\%$ infused over the next $16\,\text{hours}$.

Modified Brooke Formula

A burn fluid resuscitation protocol providing $1.5\,\text{mL/kg/\% TBSA}$ of Lactated Ringer's solution plus $0.5\,\text{mL/kg/\% TBSA}$ of colloids (such as $5\%$ albumin in isotonic saline) during the first $24\,\text{hours}$, administered as half in the first $8\,\text{hours}$ and half in the remaining $16\,\text{hours}$.

Evans and Monafo Resuscitation Formulas

Alternative burn resuscitation regimens; Evans formula utilizes $1\,\text{mL/kg/\% TBSA}$ colloid, $1\,\text{mL/kg/\% TBSA}$ saline, plus $2{,}000\,\text{mL}$ of $5\%\,\text{D/W}$ for insensible loss, while Monafo formula uses hypertonic saline ($\text{sodium} = 250\,\text{mEq/L}$) titrated to maintain urine output at $30\,\text{mL/hr}$.

Escharotomy

A surgical linear incision made through full-thickness, rigid, non-yielding circumferential burn eschar to release constriction, relieve underlying compartmental tissue pressure, restore distal arterial perfusion, or allow adequate chest excursion during mechanical ventilation.

Open vs. Closed Burn Dressing Methods

Two approaches to burn wound management: the open (exposure) method leaves the wound uncovered following topical antimicrobial application, which facilitates visualization but increases evaporative heat and fluid loss; the closed method covers the treated wound with non-adherent absorbent gauze and elastic wraps, reducing hypothermia and pain but adding time and expense.

Autograft

A permanent skin graft harvested from an uninjured donor site on the patient's own body, categorized into split-thickness skin grafts (epidermis and superficial dermis) and full-thickness skin grafts (epidermis, entire dermis, and subcutaneous elements).

Allograft (Homograft)

A temporary biologic wound dressing obtained from a human cadaver or amniotic membrane, utilized to temporarily seal extensive, debrided burn wounds, reduce evaporative water loss, and prevent infection until autografts are available, typically rejected within $1\text{--}3\,\text{weeks}$.

Heterograft (Xenograft)

A temporary biological skin covering obtained from an animal donor of a different species, most commonly porcine (pig skin), used to protect clean granulating wound surfaces until permanent autografting is achieved.

Biobrane

A biosynthetic skin substitute consisting of a semipermeable nylon-silicone membrane coated with porcine dermal collagen peptides, designed to interact with wound bed clotting factors to form an adherent, protective barrier over clean partial-thickness burns.

TransCyte

A temporary bioengineered human dermal replacement composed of human neonatal dermal fibroblasts cultured on nylon mesh with a synthetic semipermeable silicone membrane, stored frozen in dual-piece cassettes until clinical application.

Pressure Garments

Custom-tailored elastic compression garments worn continuously ($23\,\text{hours/day}$ for up to a year or more) over newly healed or grafted burn wounds to flatten collagen nodules, minimize hypertrophic scarring, and prevent joint contractures.

Glomerular Filtration Rate (GFR)

The total volume of fluid filtered from the glomerular capillaries into Bowman's capsule per unit of time, averaging approximately $125\,\text{mL/min}$ in an adult male, of which $124\,\text{mL}$ is reabsorbed across renal tubules and $1\,\text{mL}$ is excreted as urine.

Routine Urinalysis and Clean-Catch Urine Culture

Primary laboratory urine exams: routine urinalysis provides physical, chemical, and microscopic screening (normal specific gravity: $1.025\text{--}1.030$, pH: $4.5\text{--}8.0$, negative for protein/glucose/ketones), whereas a clean-catch midstream urine culture isolates and identifies specific uropathogens, with a count of $> 100{,}000\,\text{organisms/mL}$ indicative of infection.

Creatinine Clearance Test

A diagnostic 24-hour urine collection paired with a serum sample that estimates GFR by calculating the volume of blood plasma completely cleared of creatinine in one minute, with normal adult reference values ranging from $85\text{--}135\,\text{mL/min}$.

Blood Urea Nitrogen (BUN) and Serum Creatinine

Standard serum indices of renal excretory capacity; BUN (normal: $20\text{--}30\,\text{mg/dL}$) measures the nitrogen fraction of circulating urea, while Serum Creatinine (normal: $0.5\text{--}1.5\,\text{mg/dL}$) is a highly specific reflection of GFR derived from constant skeletal muscle breakdown.

Phenolsulfophthalein (PSP) Excretion Test

A renal function test in which a red diagnostic dye (PSP) is administered intravenously to assess renal plasma blood flow and proximal tubular excretory function by collecting timed urine samples at 15 minutes, 30 minutes, and 1 hour post-injection.

Intravenous Pyelogram (IVP)

An excretory radiographic study involving intravenous injection of a radiopaque iodinated dye that concentrates in the urine, producing serial X-ray visualizations of kidney parenchymal structure, calyces, renal pelvis, ureters, and bladder.

Cystoscopy

Direct visual inspection of the urethral canal and bladder interior using a rigid or flexible fiberoptic endoscope inserted transurethrally, utilized for diagnostic biopsy, stone crushing, or structural tumor evaluation.

Acute Pyelonephritis

An acute, sudden bacterial infection and inflammation of the renal pelvis and kidney parenchyma, most frequently caused by ascending Escherichia coli ($85\%$), presenting with fever, chills, flank tenderness over the costovertebral angle, dysuria, and pyuria.

Chronic Pyelonephritis

A progressive, chronic inflammation, interstitial fibrosis, and scarring of the renal tubules and pelvis resulting from repeated or unresolved infections and reflux, characterized microscopically by 'thyroidization' of the tubules and leading to chronic renal failure.

Acute Poststreptococcal Glomerulonephritis

An immune-complex-mediated inflammatory disease of the glomerular capillary basement membrane developing $10\text{--}14\,\text{days}$ following group A beta-hemolytic streptococcal infection, presenting abruptly with gross cola-colored hematuria, proteinuria, periorbital edema, oliguria, and hypertension.

Nephrotic Syndrome

A clinical constellation resulting from dramatically increased glomerular basement membrane permeability, characterized by massive proteinuria, severe hypoalbuminemia, hyperlipidemia, and generalized dependent edema (anasarca).

Urolithiasis

The formation or presence of mineral stones (calculi) within the urinary collecting system, presenting with excruciating, sharp, spasmodic flank pain (renal colic) that radiates toward the suprapubic area, groin, and external genitalia, accompanied by hematuria.

Staghorn Calculus

A large, branched urinary tract calculus that occupies the renal pelvis and extends into multiple calyces, typically composed of struvite (magnesium ammonium phosphate) associated with recurrent, urea-splitting Proteus bacterial infections.

Extracorporeal Shock Wave Lithotripsy (ESWL)

A noninvasive clinical procedure that utilizes focused acoustic shock waves generated outside the body to pulverize renal and ureteral stones into microscopic fragments small enough to be excreted spontaneously in the urine.

Acute Renal Failure (ARF)

A sudden, rapid decline in renal excretory function occurring over hours to days, leading to azotemia, fluid overload, and electrolyte derangements, which progresses through initiation, oliguric, diuretic, and recovery phases.

Prerenal, Intrarenal, and Postrenal ARF

The three etiologic categories of acute kidney injury: prerenal ($55\text{--}60\%$) caused by hypoperfusion (e.g., shock, dehydration); intrarenal ($35\text{--}40\%$) caused by direct structural damage to nephrons (e.g., ATN, glomerulonephritis, nephrotoxic drugs); and postrenal ($< 5\%$) caused by mechanical urinary outflow tract obstruction (e.g., calculi, prostatic hypertrophy).

Acute Tubular Necrosis (ATN)

The abrupt destruction and necrosis of renal tubular epithelial cells caused by prolonged renal ischemia ($> 2\,\text{hours}$) or direct exposure to nephrotoxic agents (such as aminoglycosides, radiopaque contrast media, or rhabdomyolysis-induced myoglobin casts).

Azotemia

An abnormal accumulation of nitrogenous waste products, including urea, uric acid, and creatinine, in the bloodstream, resulting from severely diminished glomerular filtration capacity in acute or chronic kidney failure.

Chronic Renal Failure (CRF) Stages

The gradual, progressive destruction of nephrons spanning: Decreased Renal Reserve ($40\text{--}75\%$ nephron loss, normal BUN/creatinine); Renal Insufficiency ($75\text{--}90\%$ loss, elevated BUN, polyuria, anemia); and End-Stage Renal Disease (ESRD, $< 10\%$ functioning nephrons).

End-Stage Renal Disease (ESRD)

The terminal state of chronic kidney disease wherein functioning nephron capacity falls below $5\text{--}10\%$ of normal, producing multisystem uremic syndrome that requires lifelong maintenance dialysis or kidney transplantation for survival.

Uremic Frost

A late dermatologic sign of advanced, untreated uremia in end-stage renal disease, presenting as a fine, white, powdery crystallization of evaporated urea excreted through the sweat onto the skin surface.

Hemodialysis

An extracorporeal renal replacement therapy in which a patient's blood is circulated through an artificial kidney (dialyzer) separated from dialysate by a semipermeable membrane, removing nitrogenous wastes, excess electrolytes, and water via diffusion and ultrafiltration.

Arteriovenous (AV) Fistula

A surgically constructed permanent vascular access for hemodialysis created by anastomosing an artery directly to a vein (typically the radial artery and cephalic vein) in the non-dominant forearm, assessed for patency by palpating a thrill and auscultating a bruit.

Peritoneal Dialysis

A renal replacement technique wherein the patient's rich, living peritoneal membrane serves as the semipermeable dialyzing surface, allowing metabolic wastes and excess fluid to diffuse into sterile dialysate instilled via an indwelling catheter before being drained by gravity.

Continuous Ambulatory Peritoneal Dialysis (CAPD)

A manual form of peritoneal dialysis performed by the patient without machinery, involving continuous intra-abdominal instillation of $2\,\text{liters}$ of dialysate that is exchanged manually $4\text{--}6\,\text{times}$ daily around the clock.

Communicable Disease

An illness caused by a specific infectious agent or its toxic products that arises through the transmission of that agent directly or indirectly from an infected human, animal, vector, or contaminated inanimate reservoir to a susceptible host.

Contagious Disease vs. Infectious Disease

A contagious disease is transmitted easily from person to person via ordinary direct or indirect contact (e.g., measles, chickenpox), whereas an infectious disease is transmitted by inoculation of microorganisms through a break in the skin or mucous membranes (e.g., tetanus, hepatitis B).

Sporadic Disease

A disease occurrence pattern marked by intermittent, isolated, and unrelated individual cases arising irregularly without geographical or temporal consistency (e.g., degenerative diseases, occasional cancers).

Endemic Disease

The continuous, baseline presence and expected usual frequency of an infectious illness within a specific population, community, or geographic region over an extended period (e.g., pulmonary tuberculosis, malaria, schistosomiasis).

Epidemic Disease

An unusual, sudden, and marked increase in the incidence of disease cases exceeding normal baseline expectancy within a localized population or region during a relatively short time span (e.g., dengue, leptospirosis, mumps).

Pandemic Disease

An extensive epidemic that has spread across international borders, simultaneously affecting multiple countries or continents worldwide (e.g., COVID-19, HIV/AIDS, SARS).

Incubation Period

The initial phase of the infectious disease continuum extending from the entry of a pathogenic microorganism into the host body up to the first onset of non-specific signs and symptoms.